Shares of Dr. Reddy's Laboratories Ltd. 500124 inched down 0.41% to 1,191.45 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

Add Yahoo as a preferred source to see more of our stories on Google. SHREVEPORT, La. (KTAL/KMSS) – Dr. Reddy’s Laboratories, a global pharmaceutical company, recently closed in early 2025 due to ...

Dr. Reddy's Laboratories Ltd. closed 10.59% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th.

The Indian drugmaker gave an oral undertaking to the Delhi High Court after Novo Nordisk alleged trademark infringement of its blockbuster semaglutide drug ‘Ozempic ...

Dr. Reddy's Lab is undervalued due to exaggerated concerns about Revlimid revenue decline and the underappreciated potential of new high-growth products like biosimilars and GLP-1 drugs. Despite the ...

View Dr. Reddy's Laboratories Ltd. Sponsored ADR RDY stock quote prices, financial information, real-time forecasts, and company news from CNN.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Stock slips over 6 per cent as regulatory setback clouds Semaglutide approval; Market guru Anil Singhvi sets downside targets ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

In the 50-share NSE Nifty 50, at the closing time 23 shares advanced, while the remaining 27 shares declined. The top 5 ...

We interacted with Dr Reddy’s Lab Head of IR, Aishwarya Sitharam, following the company’s successful day-1 launch of Semaglutide. Dr Reddy’s Lab is the first to introduce a DCGI-approved version in ...